Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations
- PMID: 30450527
- PMCID: PMC6652186
- DOI: 10.1007/s00439-018-1957-1
Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations
Abstract
Juvenile segmental progeroid syndromes are rare, heterogeneous disorders characterized by signs of premature aging affecting more than one tissue or organ starting in childhood. Hutchinson-Gilford progeria syndrome (HGPS), caused by a recurrent de novo synonymous LMNA mutation resulting in aberrant splicing and generation of a mutant product called progerin, is a prototypical example of such disorders. Here, we performed a joint collaborative study using massively parallel sequencing and targeted Sanger sequencing, aimed at delineating the underlying genetic cause of 14 previously undiagnosed, clinically heterogeneous, non-LMNA-associated juvenile progeroid patients. The molecular diagnosis was achieved in 11 of 14 cases (~ 79%). Furthermore, we firmly establish biallelic mutations in POLR3A as the genetic cause of a recognizable, neonatal, Wiedemann-Rautenstrauch-like progeroid syndrome. Thus, we suggest that POLR3A mutations are causal for a portion of under-diagnosed early-onset segmental progeroid syndromes. We additionally expand the clinical spectrum associated with PYCR1 mutations by showing that they can somewhat resemble HGPS in the first year of life. Moreover, our results lead to clinical reclassification in one single case. Our data emphasize the complex genetic and clinical heterogeneity underlying progeroid disorders.
Keywords: Hutchinson–Gilford progeria syndrome; Juvenile segmental progeroid syndrome; POLR3A; PYCR1; Wiedemann–Rautenstrauch progeroid syndrome.
Conflict of interest statement
Figures




Similar articles
-
Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome.J Med Genet. 2018 Dec;55(12):837-846. doi: 10.1136/jmedgenet-2018-105528. Epub 2018 Oct 15. J Med Genet. 2018. PMID: 30323018
-
Wiedemann-Rautenstrauch syndrome in an Indian patient with biallelic pathogenic variants in POLR3A.Am J Med Genet A. 2021 May;185(5):1602-1605. doi: 10.1002/ajmg.a.62115. Epub 2021 Feb 8. Am J Med Genet A. 2021. PMID: 33559318
-
Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A.Am J Med Genet A. 2016 Dec;170(12):3343-3346. doi: 10.1002/ajmg.a.37960. Epub 2016 Sep 9. Am J Med Genet A. 2016. PMID: 27612211
-
The neonatal progeroid syndrome (Wiedemann-Rautenstrauch): a model for the study of human aging?Exp Gerontol. 2007 Oct;42(10):939-43. doi: 10.1016/j.exger.2007.07.004. Epub 2007 Jul 19. Exp Gerontol. 2007. PMID: 17728088 Review.
-
Neonatal progeroid syndrome (Wiedemann-Rautenstrauch syndrome): report of three affected sibs.Am J Med Genet A. 2011 Jul;155A(7):1712-5. doi: 10.1002/ajmg.a.34019. Epub 2011 Jun 10. Am J Med Genet A. 2011. PMID: 21671373 Review.
Cited by
-
Biallelic PAN2 variants in individuals with a syndromic neurodevelopmental disorder and multiple congenital anomalies.Eur J Hum Genet. 2022 May;30(5):611-618. doi: 10.1038/s41431-022-01077-y. Epub 2022 Mar 18. Eur J Hum Genet. 2022. PMID: 35304602 Free PMC article.
-
The Discovery of a LEMD2-Associated Nuclear Envelopathy with Early Progeroid Appearance Suggests Advanced Applications for AI-Driven Facial Phenotyping.Am J Hum Genet. 2019 Apr 4;104(4):749-757. doi: 10.1016/j.ajhg.2019.02.021. Epub 2019 Mar 21. Am J Hum Genet. 2019. PMID: 30905398 Free PMC article.
-
Clinical and Molecular Delineation of Cutis Laxa Syndromes: Paradigms for Homeostasis.Adv Exp Med Biol. 2021;1348:273-309. doi: 10.1007/978-3-030-80614-9_13. Adv Exp Med Biol. 2021. PMID: 34807425 Review.
-
[Wiedemann-Rautenstrauch syndrome. The first description of a clinical case in the Russian Federation].Probl Endokrinol (Mosk). 2023 Oct 8;70(2):86-93. doi: 10.14341/probl13369. Probl Endokrinol (Mosk). 2023. PMID: 38796765 Free PMC article. Russian.
-
Distinguishing severe phenotypes associated with pathogenic variants in POLR3A.Am J Med Genet A. 2022 Feb;188(2):708-712. doi: 10.1002/ajmg.a.62553. Epub 2021 Nov 12. Am J Med Genet A. 2022. PMID: 34773388 Free PMC article.
References
-
- Bernard G, Chouery E, Putorti ML, Tetreault M, Takanohashi A, Carosso G, Clement I, Boespflug-Tanguy O, Rodriguez D, Delague V, Abou Ghoch J, Jalkh N, Dorboz I, Fribourg S, Teich-mann M, Megarbane A, Schiffmann R, Vanderver A, Brais B (2011) Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet 89:415–423. https://doiorg/10.1016/j.ajhg.2011.07.014 - DOI - PMC - PubMed
-
- Byers PH, Duvic M, Atkinson M, Robinow M, Smith LT, Krane SM, Greally MT, Ludman M, Matalon R, Pauker S, Quanbeck D, Schwarze U (1997) Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. Am J Med Genet 72:94–105 - PubMed
-
- Chong JX, McMillin MJ, Shively KM, Beck AE, Marvin CT, Armenteros JR, Buckingham KJ, Nkinsi NT, Boyle EA, Berry MN, Bocian M, Foulds N, Uzielli ML, Haldeman-Englert C, Hennekam RC, Kaplan P, Kline AD, Mercer CL, Nowaczyk MJ, Klein Wassink-Ruiter JS, McPherson EW, Moreno RA, Scheuerle AE, Shashi V, Stevens CA, Carey JC, Monteil A, Lory P, Tabor HK, Smith JD, Shendure J, Nickerson DA, Bamshad MJ, University of Washington Center for Mendelian G (2015) De novo mutations in NALCN cause a syndrome characterized by congenital contractures of the limbs and face, hypotonia, and developmental delay. Am J Hum Genet 96:462–473. 10.1016/ajhg.2015.01.003 - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous